Hypertensive crisis in children

Pediatric Nephrology

Volumn 27, Issue 5, 2012, Pages 741-751

  Chandar, Jayanthi ^a   Zilleruelo, Gastón ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Antihypertensive therapy; Children; Hypertension; Hypertension crisis; Hypertensive urgency

Indexed keywords

CLEVIDIPINE; CLONIDINE; ENALAPRILAT; ESMOLOL; FENOLDOPAM; FUROSEMIDE; HYDRALAZINE; ISRADIPINE; LABETALOL; MINOXIDIL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENTOLAMINE;

ACUTE KIDNEY FAILURE; ALGORITHM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; INTOXICATION; INTRACRANIAL HYPERTENSION; KIDNEY DYSFUNCTION; LUPUS LIKE SYNDROME; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REBOUND HYPERTENSION; RENOVASCULAR HYPERTENSION; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; SYMPTOM; TACHYCARDIA; THIOCYANATE TOXICITY;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; RENAL DIALYSIS;

EID: 84863462108     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1964-0     Document Type: Review

References (84)

1. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ (2004) Overweight, ethnicity and the prevalence of hypertension in school aged children. Pediatrics 113:475-482 (Pubitemid 38280786)
2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The Fourth Report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
3. Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Moralesa-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wühl E, Zanchetti A (2009) Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension. J Hypertens 27:1719-1742
4. National Heart, Lung, and Blood Institute (2003) The seventh report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 42:1206
5. Roman RJ (2003) Autoregulation of blood flow. In: Izzo JL, Black HR (eds) Hypertension primer: The essentials of high blood pressure, 3rd edn. Council for High Blood Pressure Research, American Heart Association/Lippincott-Williams & Wilkins, Philadelphia, pp 114-117
6. Houston M (1989) Pathophysiology, clinical aspects and treatment of hypertensive crisis. Progr Cardiovasc Dis 32:99-148 (Pubitemid 19227954)
7. Laragh JH, Ulick S, Januszewicw V, Deming QB, Kelly WG, Lieberman S (1960) Aldosterone secretion and primary and malignant hypertension. J Clin Invest 139:1091-1106
8. Laragh JH, Angers M, Kelly WG, Lieberman S (1960) Hypotensive agents and pressor substances. The effect of epinephrine, Angiotensin II and others on the secretory rate of aldosterone in man. JAMA 174:293-295
9. Geise J (1977) The renin angiotensin system and the pathogenesis of vascular disease in malignant hypertension. Clin Sci Mol Med 3:19s-21s
10. Fleming S (2000) Malignant hypertension-the role of the paracrine renin-angiotensin system. J Pathol 192:135-139
11. Mohring J, Mohring P, Petri M, Hack D (1977) Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol 232:F260-F269 (Pubitemid 8077474)
12. Madeddu P, Emanueli C, El-Dahr S (2007) Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling. Nat Clin Pract Nephrol 3:208-221 (Pubitemid 46496868)
13. Kincaid-Smith P (1980) Malignant hypertension: Mechanisms and management. Pharmacol Ther 9:245-269 (Pubitemid 10043937)
14. Katholi RE, Winternitz SR, Oparil S (1981) Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 3:404-409 (Pubitemid 11002036)
15. Oparil S (1986) The sympathetic nervous system in clinical and experimental hypertension. Kidney Int 30:437-452 (Pubitemid 16029517)
16. Mathias CJ, Wilkinson A, Lewis P, Peart WS, Sever PS, Snell ME (1983) Clonidine lowers blood pressure independently of renin suppression in patients with unilateral renal stenosis. Chest 83:357-359 (Pubitemid 13153322)
17. Zimmerman BG (1981) Adrenergic facilitation by angiotensin: Does it serve a physiological function. Clin Sci 60:343-348 (Pubitemid 11123437)
18. Whitworth CE, Fleming S, Cumming AD, Morton JJ, Burns NJ, Williams BC, Mullins JJ (1994) Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int 46:1528-1532 (Pubitemid 24370453)
19. Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ, McEwan JR (1998) Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR (mREN2)27. J Hypertens 16:635-643 (Pubitemid 28230552)
20. Patterson ME, Mouton CR, Mullins JJ, Mitchell KD (2005) Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol 289:754-759
21. Marvar PJ, Thabet SR, Guzek TJ, Lob HE, McCann LA, Weyand C, Gordon FJ, Harrison DG (2010) Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107:263-270
22. Leumann EP, Bauer RP, Slaton PE, Biglieri EG, HollidayMA(1970) Renovascular hypertension in children. Pediatrics 46:362-370
23. Brody MJ, Johnson AK (1980) Role of the antero-ventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation, and hypertension. Front Neuroendocrinol 6:249-292
24. Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J (2008) Renal thrombotic renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res 31:479-483 (Pubitemid 351597501)
25. Zubrow AB, Hulman S, Kushner H, Falkner B (1995) Determinants of blood pressure in infants admitted to neonatal intensive care units: A prospective multicenter study. J Perinatol 15:470-479
26. Flynn JT (2000) Neonatal hypertension: Diagnosis and management. Pediatr Nephrol 14:332-341 (Pubitemid 30166719)
27. Calenda E, Richez F, Muraine M (2007) Acute hypertension due to phenylephrine eyedrops in a newborn. Can J Opthalmol 42:486 (Pubitemid 46932055)
28. Baker MD (1986) Theophylline toxicity in children. J Pediatr 109:538-542 (Pubitemid 16014290)
29. Saland JM, Mahony L, Baum M (2001) Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics 107:185-186
30. Brody SL, Slovis CM, Wrenn KD (1990) Cocaine related medical problems: Consecutive series of 233 patients. AmJ Med 119:226-235
31. Drees JC, Stone JA, Wu AHB (2009) Morbidity involving the hallucinogenic amines MDA and 2C-I. J Forensic Sci 54:1485-1487
32. Armstrong EP, Malone DC (2003) The impact of nonsteroidal anti-inflammatory drugs on blood pressure with an emphasis on newer agents. Clin Ther 25:1-18 (Pubitemid 36206735)
33. Mitsnefes M, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309-315 (Pubitemid 40431057)
34. Horl MP, Horl WH (2002) Hemodialysis-associated hypertension: Pathophysiology and therapy. Am J Kidney Dis 39(2):227-244 (Pubitemid 34174245)
35. Vonend O, Rump LC, Ritz E (2008) Sympathetic overactivity-the Cinderella of cardiovascular risk factors in dialysis patients. Semin Dial 21:327-330
36. Meyers K, Falkner B (2009) Hypertension in children and adolescents: An approach to management of complex hypertension in pediatric patients. Curr Hypertens Rep 11:315-352
37. Tullus K, Brennan E, Hamilton G, Lord R, McLaren CA, Marks SD, Roebuck DJ (2008) Renovascular hypertension in children. Lancet 371:1453-1463 (Pubitemid 351618339)
38. Eklof H, Ahlstrom H, Magnusson A, Anderson LG, Andren B, Hagg A, Bergqvist D, Nyman R (2006) A prospective comparison of duplex ultrasonography, captopril renography, MRA and CTA in assessing renal artery stenosis. Acta Radiol 47:764-774 (Pubitemid 44521233)
39. Marshalleck F (2010) Pediatric arterial interventions. Tech Vasc Interv Radiol 13:238-243
40. Luke RG (1991) Pathophysiology and treatment of post-transplant hypertension. J Am Soc Nephrol 2:S37-S44
41. Kaul A, Sharma RK, Gupta A, Singh U (2010) Spectrum of hypertension in post transplant. J Assoc Physicians India 58:221-224
42. Zarifian A, Meleg-Smith S, O'Donovan R, Tesi RJ, Batuman V (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 55:2457-2466 (Pubitemid 29256501)
43. Robson M, Côte I, Abbs I, Koffman G, Goldsmith D (2003) Thrombotic micro-angiopathy with sirolimus-based immunesuppression: Potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant 3:324-327 (Pubitemid 36407052)
44. Ozen S, Celik A, Alper H, Simsek DG, Darcan S (2010) Primary hyperparathyroidism in a young adult presenting with severe hypertension. J Pediatr Endocrinol Metab 23:193-196
45. Grinsell MM, Norwood VF (2009) At the bottom of the differential diagnosis list: Unusual causes of pediatric hypertension. Pediatr Nephrol 24:2137-2146
46. Chan JC, Young RB, Alon U, Mamunes P (1983) Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3. Pediatrics 72:225-233 (Pubitemid 13030220)
47. Van der Horst-Schrivers ANA, Kerstens MN, Wolffenbuttel BHR (2006) Pre-operative pharmacological management of phaeochromocytoma. Neth J Med 64:290-295
48. Nussberger J (2003) Investigating mineralocorticoid hypertension. J Hypertens Suppl 21(2):S25-S30 (Pubitemid 36900679)
49. Abend NS, Bonnemann CG, Licht DJ (2007) Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain barre Syndrome. Pediatr Emerg Care 23:659-661 (Pubitemid 47429066)
50. Kwon S, Koo J, Lee S (2001) Clinical Spectrum of reversible posterior encephalopathy syndrome. Pediatr Neurol 24:361-364
51. Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hijazi R, Chandar J, Abitbol C, Zilleruelo G (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22:1921-1929 (Pubitemid 47506233)
52. Lee VH, Wijdicks EF, Manno EM, Rabinstain AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65:205-210 (Pubitemid 351240781)
53. Mehta JL, Lopez LM (1987) Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol. Arch Intern Med 147:389-390 (Pubitemid 17040270)
54. Piccoli GB, Anania P, Biancone L, Mezza E, Vischi M, Jeantet A, Rabbia C, Savio D, Rossatto D, Gai M, Perin PC, Segoloni GP (2001) Hypertensive rebound after angiotensin converting enzyme inhibitor withdrawal in diabetic patients with chronic renal failure. Nephrol Dial Transplant 16:1084-1085 (Pubitemid 32440398)
55. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sg S, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurements in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111:697-716 (Pubitemid 40216499)
56. Chiolero A, Paradis G, Lambert M (2010) Accuracy of oscillometric devices in children and adults. Blood Press 19:254-259
57. McGhee BH, Bridges EJ (2002) Monitoring arterial blood pressure: What you may not know. Crit Care Nurse 22:60-79
58. Colan SD, Fujii A, Borow KM, MacPherson D, Sanders SP (1983) Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children: Comparison with central aortic pressure measurements. Am J Cardiol 52:867-870 (Pubitemid 13023776)
59. Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: Pathophysiology and treatment. Pediatr Nephrol 24:1101-1112
60. Flynn JT, Mottes TA, Brophy PB, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38-43 (Pubitemid 32613985)
61. Michael J, Groshong T, Tobias JD (1998) Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12:40-42 (Pubitemid 28165779)
62. Bunchman TE, Lynch RE, Wood EG (1992) Intravenously administered labetalol for treatment of malignant hypertension in children. J Pediatr 120:140-144
63. Thomas CA, Moffett BA, Wagner JL, Mott AR, Feig DI (2011) Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28-32
64. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein M, Kjeckshus J, Philippe L, Torp-Pederson C (2004) Expert consensus document on β adrenergic receptor blockers. Eur Heart J 25:1341-1362
65. Weist DB, Garner SS, Uber WE, Sade RM (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890-897 (Pubitemid 28196601)
66. Panacek EA, Bednarczyk EM, Dunbar LM, Foulke GE, Holkslaw TL (1995) Randomized, prospective trial of fenoldapam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldapam Study Group. Acad Emerg Med 2:959-965
67. Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR (2008) Pharmacokinetics and pharmacodynamics of fenoldapammesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6-15
68. Gordillo-Paniagua G, Velasquez Jones L, Martini R, Valdez Bolanos E (1975) Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 87:799-802
69. Wells TG, Bunchman TE, Kearns GL (1990) Treatment of neonatal hypertension with enalaprilat. J Pediatr 117:664-667
70. Gantenbein MH, Bauersfeld U, Baenziger O, Frey B, Neuhaus T, Sennhauser F, Bernet V (2008) Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants. J Perinat Med 36:448-452
71. Towe E, Tobias JD (2010) Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med 25:349-352
72. Joynt KE, Moslehi JJ, Baughman KL (2009) Paragangliomas: Etiology, presentation, and management. Cardiol Rev 17:159-164
73. Rodriguez MA, Kumar SK, De Caro M (2010) Hypertensive Crisis. Cardiol Rev 18:102-107
74. Johnson CE, Jacobson PA, Song MH (1997) Isradipine therapy in hypertensive pediatric patients. Ann Pharmacother 31:704-707 (Pubitemid 27242376)
75. Miyashita Y, Peterson D, Reese JN, Flynn JT (2010) Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens 12:850-855
76. Blaszak T, Savage JA, Ellis EN (2001) The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr 139:34-37 (Pubitemid 32613984)
77. Castenada MP, Walsh CA, Woroniecki RP, Del Rio M, Flynn JT (2005) Ventricular arrhythmia following short acting nifedipine administration. Pediatr Nephrol 20:1000-1002 (Pubitemid 40909277)
78. Wong H, Hadi M, Khoury T, Geary D, Rubin B, Guido F (2006) Management of severe hypertension in a child with tuberous sclerosisrelated major vascular abnormalities. J Hypertens 24:597-599 (Pubitemid 43261925)
79. Strife CF, Quinlan M, Waldo FB, Fryer CJ, Jackson EC, Welch TR, McEnery PT, West CD (1986) Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics 78:861-865 (Pubitemid 17170696)
80. Martin WB, Spodlick DH, Zins GR (1980) Pericardial disorders occurring during open-label study of 1869 severely hypertensive patients treated with minoxidil. J Cardiovasc Pharmacol 2:S217-227 (Pubitemid 10125571)
81. Chandar JJ, Sfakianakis GN, Zilleruelo GE, Guerra JJ, Georgiou MF, Abitbol CL, Montane BS, Strauss J (1999) ACE inhibition scintigraphy in the management of hypertension in children. Pediatr Nephrol 13:493-500 (Pubitemid 29348704)
82. Sfakianakis GN, Sfakianaki E, Paredes A, Abitbol C, Zilleruelo G, Goldberg RN, Strauss J (1988) Single-dose captopril scintigraphy in the neonate with renovascular hypertension: Prediction of renal failure, a side effect of captopril therapy. Biol Neonate 54:246-253
83. Deal JE, Barratt TM, Dillon MJ (1992) Management of hypertensive emergencies. Arch Dis Child 67:1089-1092
84. Hulse JA, Taylor DS, Dillon MJ (1979) Blindness and paraplegia in severe childhood hypertension. Lancet 2(8142):553-556